Kaempferol ameliorates BMSCs senescence in postmenopausal osteoporosis by targeting Sp1 to activate FUNDC1-mediated mitophagy
Open Access
- 25 October 2025
- journal article
- Published by Elsevier in Phytomedicine
- Vol. 148, 157456
Abstract
No abstract availableKeywords
Funding Information
- Department of Science and Technology of Liaoning Province
- Liaoning Provincial Natural Science Foundation (2022-YGJC-42)
- Liaoning Provincial Natural Science Foundation (2022JH1/10800073)
This publication has 63 references indexed in Scilit:
- Treatment of Osteoporosis and Osteoarthritis in the Oldest OldDrugs, 2025
- Stiff extracellular matrix drives the differentiation of mesenchymal stem cells toward osteogenesis by the multiscale 3D genome reorganizationBiomaterials, 2024
- Protosappanin A Protects DOX‐Induced Myocardial Injury and Cardiac Dysfunction by Targeting ACSL4/FTH1 Axis‐Dependent FerroptosisAdvanced Science, 2024
- Kaempferol‐Enhanced Migration and Differentiation of C2C12 Myoblasts via ITG1B/FAK/Paxillin and IGF1R/AKT/mTOR Signaling PathwaysMolecular Nutrition & Food Research, 2024
- The role of mitochondrial quality surveillance in skin aging: Focus on mitochondrial dynamics, biogenesis and mitophagyAgeing Research Reviews, 2023
- Hallmarks of aging: An expanding universeCell, 2023
- DNA damage-induced degradation of Sp1 promotes cellular senescenceGeroScience, 2021
- DSB repair pathway choice is regulated by recruitment of 53BP1 through cell cycle-dependent regulation of Sp1Cell Reports, 2021
- Muscle mass measures and incident osteoporosis in a large cohort of postmenopausal womenJournal of Cachexia, Sarcopenia and Muscle, 2018
- Estrogen therapy for osteoporosis in the modern eraOsteoporosis International, 2018